Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Dec 11;29(2):434–442. doi: 10.1158/1055-9965.EPI-19-0887

Table 2:

Top 10 HLOD Scores from the All Aggregated Cancers Analysis

CHR POS TYPE rsID CLOD HLOD ALPHA FUNC GENE
12 106751805 SNV rs61943670 3.3 3.3 1.0 intron POLR3B
20 31660489 SNV rs11700200 3.2 3.2 1.0 intron BPIFB3
20 31671599 SNV rs13036385 3.1 3.1 1.0 nonsyn exon BPIFB4
9 5233558 DEL N/A 3.0 3.0 1.0 intron INSL4
16 4923091 SNV rs2251666 3.0 3.0 1.0 intron UBN1
20 31671209 SNV rs4339026 2.9 2.9 1.0 nonsyn exon BPIFB4
3 10258762 SNV rs2302860 2.8 2.8 1.0 intron IRAK2
20 31678534 SNV rs2070326 2.8 2.8 1.0 syn exon BPIFB4
6 146207563 SNV rs1062067 2.8 2.8 1.0 ncRNA LOC100507557
3 10261294 SNV rs3895947 2.8 2.8 1.0 intron IRAK2

HLOD scores for Top Ten Variants in the All Aggregated Cancers (AAC) analysis. Headers are as follows: CHR = chromosome, POS = position of the variant in basepairs (hg 19), TYPE = Type of variant; either single nucleotide variant (SNV) or deletion (DEL), rsID = rsID of the variant (if applicable), CLOD = cumulative LOD score of the variant across all 28 families, HLOD = heterogeneity LOD score of the variant across all 28 families, ALPHA = Alpha value of variant used in HLOD score calculation, FUNC = functional description of the variant; nonsynonymous exonic (nonsyn exon), synonymous exonic (syn exon), noncoding RNA (ncRNA), or intronic (intron), GENE = gene location of the variant.